This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baserga, R., 1995, The insulin-like growth factor I receptor: A key to tumor growth? Cancer Res55:249–252.
Baserga, R., and Rubin, R., 1993, Cell cycle and growth control. Crit Rev Eukaryot Gene Expr3:47–61.
Burfeind, P., Chernicky, C.L., Rininsland, F., Ilan, J., and Ilan, J., 1996, Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci USA93:7263–7268.
Canalis, E., McCarthy, T.L., and Centrella, M., 1991, Growth factors and cytokines in bone cell metabolism. Annu Rev Med42:17–24.
Chan, J.M., Stampfer, M.J., Giovannucci, E., Gann, P.H., Ma, J., Wilkinson, P., Hennekens, C.H., and Pollak, M., 1998, Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science279:563–566.
Dunn, S.E., Ehrlich, M., Sharp, N.J., Reiss, K., Solomon, G., Hawkins, R., Baserga, R., and Barrett, J.C., 1998, A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion. and metastasis of breast cancer. Cancer Res58:3353–3361.
Guo, Y., 1997, Immunogene therapy: Both in vitro and in vivo gene transfer approaches, in: Cancer Gene Therapy (H. Mazarakis, and S.J. Swart, eds.), pp. 155–168, International Business Communicatins, Inc., Southborough.
Han, V.K., D’Ercole, A.J., and Lund, P.K., 1987, Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science236:193–197.
Heldin, C.H., and Westermark, B., 1989, Growth factors as transforming proteins. Eur J Biochem184:487–496.
Kiess, W., Lee, L., Graham, D.E., Greenstein, L., Tseng, L.Y., Rechler, M.M., and Nissley, S.P., 1989, Rat C6 glial cells synthesize insulin-like growth factor I (IGF-I) and express IGF-I receptors and IGF-II/mannose 6-phosphate receptors. Endocrinology124:1727–1736.
Lee, C.T., Wu, S., Gabrilovich, D., Chen, H., Nadaf-Rahrov, S., Ciernik, I.F., and Carbone, D.P., 1996., Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res56:3038–3041.
LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts. C.T. Jr., 1995, Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev16:143–163.
Long, L., Rubin, R., Baserga, R., and Brodt, P., 1995, Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res55:1006–1009.
Mohan, S., and Baylink, D.J., 1991, Bone growth factors. Clin Orthop263:30–48.
Morrison, R.S., 1991, Suppression of basic fibroblast growth factor expression by antisense oligodeoxynu-cleotides inhibits the growth of transformed human astrocytes. J Biol Chem266:728–734.
Müller, M., Dietel, M., Turzynski, A., and Wiechen, K., 1998, Antisense phosphorothioate oligodeoxynu-cleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells. Int J Cancer77:567–571.
Negroni, A., Scarpa, S., Romeo, A., Ferrari, S., Modesti, A., and Raschella, G., 1991, Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ2:511–518.
Palmiter, R.D., Norstedt, G., Gelinas, R.E., Hammer, R.E., and Brinster, R.L., 1983, Metallothionein-human GH fusion genes stimulate growth of mice. Science222:809–814.
Peyrat, J.P., and Bonneterre, J., 1992, Type 1 IGF receptor in human breast diseases. Breast Cancer Res Treat22:59–67.
Peyrat, J.P., Bonneterre, J., Hecquet, B., Vennin, P., Louchez, M.M., Fournier, C., Lefebvre, J., and Demaille, A., 1993, Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer29A:492–497.
Resnicoff, M., and Baserga, R., 1998, The role of the insulin-like growth factor I receptor in transformation and apoptosis. Ann N Y Acad Sci842:76–81.
Resnicoff, M., Coppola, D., Sell, C., Rubin, R., Ferrone, S., and Baserga, R., 1994a, Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res54:4848–4850.
Resnicoff, M., Sell, C., Rubini, M., Coppola, D., Ambrose, D., Baserga, R., and Rubin, R., 1994b, Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-I) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res54:2218–2222.
Rininsland, F., Johnson, T.R., Chernicky, C.L., Schulze, E., Burfeind, P., and Ilan, J., 1997, Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc Natl Acad Sci USA94:5854–5859.
Rubin, R., and Baserga, R., 1995, Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab Invest73:311–331.
Sara, V.R., and Hall, K., 1990, Insulin-like growth factors and their binding proteins. Physiol Rev70:591–614.
Trojan, J., Blossey, B.K., Johnson, T.R., Rudin, S.D., Tykocinski, M., Ilan, J., and Ilan, J., 1992, Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci USA89:4874–4878.
Trojan, J., Johnson, T.R., Rudin, S.D., Ilan, J., Tykocinski, M.L., and Ilan, J., 1993, Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science259:5091 94–97.
Trojan, J., Johnson, T.R., Rudin, S.D., Blossey, B.K., Kelley, K.M., Shevelev, A., and Abdul-Karim, F.W., Anthony D.D., Tykocinski M.L., and Ilan J., 1994, Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation. Proc Natl Acad Sci USA91:6088–6092.
Trojan, J., Duc, H.T., Lafarge-Frayssinet, C., Upegui-Gonzales, L.C., Swiercz, B., Bismuth, H., Hor, F., Anthony, D., Guo, Y., and Ilan, J., 1996a, Immunotherapy of tumors expressing IGF-I. C R Seances Soc Biol Fil190:165–169.
Trojan, J., Duc, H.T., Upegui-Gonzalez, L.C., Hor, F., Guo, Y., Anthony, D., and Ilan, J., 1996b, Presence of MHC-I and B-7 molecules in rat and human glioma cells expressing antisense IGF-I mRNA. Neurosci Lett212:9–12.
Ullrich, A., Gray, A., Tam, A.W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., and Chen, E., 1986, Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J5:2503–2512.
Whitesell, L., Rosolen, A., and Neckers, L.M., 1991, Episome-generated N-myc antisense RNA restricts the differentiation potential of primitive neuroectodermal cell lines. Mol Cell Biol11:1360–1371.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Hao, W., Yanjun, L., Lixin, W., Yajun, G. (2002). Antisense IGF and Antisense IGF-IR Therapy of Malignancy. In: Habib, N.A. (eds) Cancer Gene Therapy. Advances in Experimental Medicine and Biology, vol 465. Springer, New York, NY. https://doi.org/10.1007/0-306-46817-4_23
Download citation
DOI: https://doi.org/10.1007/0-306-46817-4_23
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-306-46191-0
Online ISBN: 978-0-306-46817-9
eBook Packages: Springer Book Archive